Results 91 to 100 of about 2,050 (152)
The novel fluorocycline antibiotic eravacycline is in development for use in the treatment of serious infections caused by susceptible and multidrug-resistant (MDR) aerobic and anaerobic Gram-negative and Gram-positive pathogens.
Trudy H. Grossman +5 more
core +1 more source
This meta-analysis assessed the efficacy and safety of novel tetracyclines for treating acute bacterial infections. Data from PubMed, Web of Science, EBSCO, Cochrane databases, Ovid Medline, and Embase databases were accessed until 11 July 2019.
Shao-Huan Lan +6 more
doaj +1 more source
Clinical Efficacy of Eravacycline in the Treatment of Pneumonia: A Multicenter Real World Study
ObjectiveTo evaluate the efficacy and safety of eravacycline in the treatment of pulmonary infections based on real-world data.MethodsThis multicenter retrospective cohort study enrolled patients with pulmonary infections who received eravacycline ...
WANG Di +7 more
doaj +1 more source
This study aims to assess the clinical efficacy and safety of eravacycline for treating complicated intra-abdominal infection (cIAI) in adult patients.
Shao-Huan Lan +4 more
core +1 more source
Additional file 4.LC/MS–MS proteomic analysis of OMVs from eravacycline treated and control strains of A.
Zhaoliang Su (396851) +6 more
core +1 more source
Eravacycline is a novel, fully synthetic fluorocycline antibiotic developed for the treatment of serious infections, including those caused by multidrug-resistant (MDR) pathogens.
Karlowsky, James A +7 more
core +1 more source
In vitro activity of omadacycline and eravacycline against Nocardia brasiliensis isolates
Actinomycetoma is a chronic, debilitating, neglected tropical disease primarily caused by Nocardia brasiliensis in Mexico and Central America. Current therapeutic standards involving high-dose trimethoprim–sulfamethoxazole are often complicated by ...
Hassiel Aurelio Ramírez-Marín +2 more
doaj +1 more source
Importance: Eravacycline is a novel, fully synthetic fluorocycline antibiotic of the tetracycline class with in vitro activity against clinically important gram-negative, gram-positive aerobic, and facultative bacteria including most of those resistant ...
Lee, Patrick, MD
core
ObjectiveTo identify genes related to eravacycline resistance in Stenotrophomonas maltophilia (Sm) and to provide a theoretical basis for the study of eravacycline resistance mechanisms in Sm and the development of new antibiotics.MethodsThe study ...
Jie Wu, Jiarong Song, Junchang Cui
doaj +1 more source

